Argiriadi Maria A, Xiang Tao, Wu Chengbin, Ghayur Tariq, Borhani David W
Department of Biochemistry, Abbott Laboratories, Worcester, Massachusetts 01605, USA.
J Biol Chem. 2009 Sep 4;284(36):24478-89. doi: 10.1074/jbc.M109.023887. Epub 2009 Jun 24.
The unique cytokine interleukin-18 (IL-18) acts synergistically with IL-12 to regulate T-helper 1 and 2 lymphocytes and, as such, seems to underlie the pathogenesis of various autoimmune and allergic diseases. Several anti-IL-18 agents are in clinical development, including the recombinant human antibody ABT-325, which is entering trials for autoimmune diseases. Given competing cytokine/receptor and cytokine/receptor decoy interactions, understanding the structural basis for recognition is critical for effective development of anti-cytokine therapies. Here we report three crystal structures: the murine antibody 125-2H Fab fragment bound to human IL-18, at 1.5 A resolution; the 125-2H Fab (2.3 A); and the ABT-325 Fab (1.5 A). These structures, along with human/mouse IL-18 chimera binding data, allow us to make three key observations relevant to the biology and antigenic recognition of IL-18 and related cytokines. First, several IL-18 residues shift dramatically (> 10 A) upon binding 125-2H, compared with unbound IL-18 (Kato, Z., Jee, J., Shikano, H., Mishima, M., Ohki, I., Ohnishi, H., Li, A., Hashimoto, K., Matsukuma, E., Omoya, K., Yamamoto, Y., Yoneda, T., Hara, T., Kondo, N., and Shirakawa, M. (2003) Nat. Struct. Biol. 10, 966-971). IL-18 thus exhibits plasticity that may be common to its interactions with other receptors. Related cytokines may exhibit similar plasticity. Second, ABT-325 and 125-2H differ significantly in combining site character and architecture, thus explaining their ability to bind IL-18 simultaneously at distinct epitopes. These data allow us to define the likely ABT-325 epitope and thereby explain the distinct neutralizing mechanisms of both antibodies. Third, given the high 125-2H potency, 10 well ordered water molecules are trapped upon complex formation in a cavity between two IL-18 loops and all six 125-2H complementarity-determining regions. Thus, counterintuitively, tight and specific antibody binding may in some cases be water-mediated.
独特的细胞因子白细胞介素-18(IL-18)与IL-12协同作用,调节辅助性T细胞1和2淋巴细胞,因此似乎是各种自身免疫性疾病和过敏性疾病发病机制的基础。几种抗IL-18药物正在进行临床开发,包括重组人抗体ABT-325,它已进入自身免疫性疾病的试验阶段。鉴于细胞因子/受体和细胞因子/受体诱饵之间存在竞争相互作用,了解识别的结构基础对于抗细胞因子疗法的有效开发至关重要。在此,我们报告了三种晶体结构:与人类IL-18结合的鼠源抗体125-2H Fab片段,分辨率为1.5埃;125-2H Fab(2.3埃);以及ABT-325 Fab(1.5埃)。这些结构,连同人/鼠IL-18嵌合体结合数据,使我们能够得出与IL-18及相关细胞因子的生物学和抗原识别相关的三个关键观察结果。第一,与未结合的IL-18相比,结合125-2H后,几个IL-18残基发生了显著位移(>10埃)(加藤,Z.,吉,J.,志贺野,H.,三岛,M.,大木,I.,大西,H.,李,A.,桥本,K.,松久间,E.,大谷,K.,山本,Y.,米田,T.,原,T.,近藤,N.,和白川,M.(2003年)《自然结构生物学》10,966 - 971)。因此,IL-18表现出可塑性,这可能是其与其他受体相互作用所共有的。相关细胞因子可能也表现出类似的可塑性。第二,ABT-325和125-2H在结合位点特征和结构上有显著差异,从而解释了它们能够在不同表位同时结合IL-18的能力。这些数据使我们能够确定可能的ABT-325表位,从而解释两种抗体不同的中和机制。第三,鉴于125-2H的高效性,在两个IL-18环和所有六个125-2H互补决定区之间的一个腔内形成复合物时,有10个排列有序的水分子被困住。因此,与直觉相反,紧密且特异性的抗体结合在某些情况下可能是由水介导的。